Stock Alert: GPT Infra, Oriental Rail Infra, Biocon, KEC International, United Drilling Tools

Image
Last Updated : Dec 15 2025 | 9:04 AM IST
Securities in F&O Ban:

Bandhan Bank shares are banned from F&O trading on 15 December 2025.

Key Events to Watch:

Indian Prime Minister Narendra Modi will begin his two-day visit to Jordan, meet King Abdullah II bin Al Hussein.

Government to release wholesale price inflation and trade data for November.

IPO Update:

Park Medi World: The public issue was subscribed 8.10 times on the final day of bidding, driven by strong demand from institutional investors. The QIB portion was subscribed 11.48 times, while the NII segment saw 15.15 times subscription. The retail category was subscribed 3.16 times.

Also Read

Nephrocare Health Services: The IPO garnered robust response, with the issue subscribed 13.96 times on Day 3. Bids were led by QIBs at 27.47 times, followed by NIIs at 24.27 times. The retail portion was subscribed 2.31 times.

ICICI Prudential AMC: The public issue was subscribed 72% on Day 1 of bidding. The QIB segment was subscribed 1.97 times, while the NII and retail portions were subscribed 37% and 21%, respectively.

IPO Listings:

Corona Remedies: The pharmaceutical company, with a presence in womens healthcare and cardiology, makes its market debut today. The IPO was priced at Rs 1,062 per share and witnessed an overwhelming response, with the issue subscribed 137 times.

Wakefit Innovations: The Indian direct-to-consumer home and sleep solutions company is also set to list today. The IPO was offered at Rs 195 per share and was subscribed 2.5 times.

Stocks to Watch:

GPT Infraprojects announced that it has received a contract worth Rs 53.6 crore from PCMM, South Eastern Railway for the supply of concrete sleepers from its factory in Panagarh, West Bengal.

Oriental Rail Infrastructure announced that its wholly owned subsidiary, Oriental Foundry, has secured an order worth Rs 1.10 crore from North Western Railway.

Biocon announced that its subsidiary, Biocon Biologics, has entered into a new settlement and license agreement with Regeneron and Bayer for its biosimilar Aflibercept (40mg/ml), Yesafili, covering Europe and the rest of the world.

KEC International announced that it has secured new orders worth Rs 1,150 crore across its transmission and distribution (T&D) and civil businesses in India.

United Drilling Tools announced that it has received an export order worth Rs 3 crore from Nigeria-based Weafri Well Services Company.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 15 2025 | 7:19 AM IST

Next Story